Lamina
Strasbourg, FR · 1 known investors
Lamina Therapeutics develops Lamina.One, a combined advanced therapy medicinal product for bone and cartilage regeneration that pairs a biodegradable polymeric membrane with hydroxyapatite and an autologous mesenchymal stem cell hydrogel to treat knee osteoarthritis and orthopaedic, maxillofacial, and periodontal conditions. A spin-off from INSERM and the University of Strasbourg's Regenerative Nanomedicine unit, it has EMA and ANSM authorization for a Phase I clinical trial in Strasbourg, France.
Founders & leadership
NB
Nadia Benkirane-JesselFounder
SL
Stephan LemmensCEO
Investors · 1
Frequently asked questions
- What does Lamina do?
- Lamina Therapeutics develops Lamina.One, a combined advanced therapy medicinal product for bone and cartilage regeneration that pairs a biodegradable polymeric membrane with hydroxyapatite and an autologous mesenchymal stem cell hydrogel to treat knee osteoarthritis and orthopaedic, maxillofacial, and periodontal conditions. A spin-off from INSERM and the University of Strasbourg's Regenerative Nanomedicine unit, it has EMA and ANSM authorization for a Phase I clinical trial in Strasbourg, France.
- Who founded Lamina?
- Lamina was founded by Nadia Benkirane-Jessel.
- Who are Lamina's investors?
- Lamina's investors include NLC.
- Where is Lamina headquartered?
- Lamina is headquartered in Strasbourg, FR.